IBDEI06E ; ; 09-FEB-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,8547,1,3,0)
 ;;=3^Vis Field Defect
 ;;^UTILITY(U,$J,358.3,8547,1,4,0)
 ;;=4^368.40
 ;;^UTILITY(U,$J,358.3,8547,2)
 ;;=^126859
 ;;^UTILITY(U,$J,358.3,8548,0)
 ;;=369.4^^53^575^58
 ;;^UTILITY(U,$J,358.3,8548,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8548,1,3,0)
 ;;=3^Legally Blind,USA Definition
 ;;^UTILITY(U,$J,358.3,8548,1,4,0)
 ;;=4^369.4
 ;;^UTILITY(U,$J,358.3,8548,2)
 ;;=Legal Blindness^268887
 ;;^UTILITY(U,$J,358.3,8549,0)
 ;;=250.01^^53^575^21
 ;;^UTILITY(U,$J,358.3,8549,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8549,1,3,0)
 ;;=3^DM Type I w/o Eye Disease
 ;;^UTILITY(U,$J,358.3,8549,1,4,0)
 ;;=4^250.01
 ;;^UTILITY(U,$J,358.3,8549,2)
 ;;=Diabetes Mellitus Type I^33586
 ;;^UTILITY(U,$J,358.3,8550,0)
 ;;=V08.^^53^575^40
 ;;^UTILITY(U,$J,358.3,8550,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8550,1,3,0)
 ;;=3^HIV Positive
 ;;^UTILITY(U,$J,358.3,8550,1,4,0)
 ;;=4^V08.
 ;;^UTILITY(U,$J,358.3,8550,2)
 ;;=Asymptomatic HIV Status^303392
 ;;^UTILITY(U,$J,358.3,8551,0)
 ;;=921.0^^53^575^16
 ;;^UTILITY(U,$J,358.3,8551,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8551,1,3,0)
 ;;=3^Contusion of Eye
 ;;^UTILITY(U,$J,358.3,8551,1,4,0)
 ;;=4^921.0
 ;;^UTILITY(U,$J,358.3,8551,2)
 ;;=^15052
 ;;^UTILITY(U,$J,358.3,8552,0)
 ;;=379.91^^53^575^87
 ;;^UTILITY(U,$J,358.3,8552,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8552,1,3,0)
 ;;=3^Pain in/around the Eye
 ;;^UTILITY(U,$J,358.3,8552,1,4,0)
 ;;=4^379.91
 ;;^UTILITY(U,$J,358.3,8552,2)
 ;;=Pain in or around eye^89093
 ;;^UTILITY(U,$J,358.3,8553,0)
 ;;=V58.69^^53^575^44
 ;;^UTILITY(U,$J,358.3,8553,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8553,1,3,0)
 ;;=3^Hi-Risk Med,Long Term Current Use
 ;;^UTILITY(U,$J,358.3,8553,1,4,0)
 ;;=4^V58.69
 ;;^UTILITY(U,$J,358.3,8553,2)
 ;;=^303460
 ;;^UTILITY(U,$J,358.3,8554,0)
 ;;=871.4^^53^575^54
 ;;^UTILITY(U,$J,358.3,8554,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8554,1,3,0)
 ;;=3^Laceration of Eyeball
 ;;^UTILITY(U,$J,358.3,8554,1,4,0)
 ;;=4^871.4
 ;;^UTILITY(U,$J,358.3,8554,2)
 ;;=Laceration of Eyeball^274889
 ;;^UTILITY(U,$J,358.3,8555,0)
 ;;=242.90^^53^575^108
 ;;^UTILITY(U,$J,358.3,8555,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8555,1,3,0)
 ;;=3^Thyroid Eye Dis
 ;;^UTILITY(U,$J,358.3,8555,1,4,0)
 ;;=4^242.90
 ;;^UTILITY(U,$J,358.3,8555,2)
 ;;=Thyroid Eye Dis^267811^376.21
 ;;^UTILITY(U,$J,358.3,8556,0)
 ;;=135.^^53^575^101
 ;;^UTILITY(U,$J,358.3,8556,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8556,1,3,0)
 ;;=3^Sarcoidosis
 ;;^UTILITY(U,$J,358.3,8556,1,4,0)
 ;;=4^135.
 ;;^UTILITY(U,$J,358.3,8556,2)
 ;;=Sarcoidosis^107916
 ;;^UTILITY(U,$J,358.3,8557,0)
 ;;=446.5^^53^575^107
 ;;^UTILITY(U,$J,358.3,8557,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8557,1,3,0)
 ;;=3^Temporal Arteritis
 ;;^UTILITY(U,$J,358.3,8557,1,4,0)
 ;;=4^446.5
 ;;^UTILITY(U,$J,358.3,8557,2)
 ;;=Temporal Arteritis^117658
 ;;^UTILITY(U,$J,358.3,8558,0)
 ;;=401.9^^53^575^49
 ;;^UTILITY(U,$J,358.3,8558,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8558,1,3,0)
 ;;=3^Hypertension
 ;;^UTILITY(U,$J,358.3,8558,1,4,0)
 ;;=4^401.9
 ;;^UTILITY(U,$J,358.3,8558,2)
 ;;=Hypertension^186630
 ;;^UTILITY(U,$J,358.3,8559,0)
 ;;=V72.0^^53^575^32
 ;;^UTILITY(U,$J,358.3,8559,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8559,1,3,0)
 ;;=3^Eye Exam
 ;;^UTILITY(U,$J,358.3,8559,1,4,0)
 ;;=4^V72.0
 ;;^UTILITY(U,$J,358.3,8559,2)
 ;;=Eye Exam^43432
 ;;^UTILITY(U,$J,358.3,8560,0)
 ;;=V41.0^^53^575^91
 ;;^UTILITY(U,$J,358.3,8560,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8560,1,3,0)
 ;;=3^Problems with Sight
 ;;^UTILITY(U,$J,358.3,8560,1,4,0)
 ;;=4^V41.0
 ;;^UTILITY(U,$J,358.3,8560,2)
 ;;=^295427
 ;;^UTILITY(U,$J,358.3,8561,0)
 ;;=998.59^^53^575^89
 ;;^UTILITY(U,$J,358.3,8561,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8561,1,3,0)
 ;;=3^Post Op Infection
 ;;^UTILITY(U,$J,358.3,8561,1,4,0)
 ;;=4^998.59
 ;;^UTILITY(U,$J,358.3,8561,2)
 ;;=Post Op Infection^97081
 ;;^UTILITY(U,$J,358.3,8562,0)
 ;;=042.^^53^575^1
 ;;^UTILITY(U,$J,358.3,8562,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8562,1,3,0)
 ;;=3^AIDS,Unspec
 ;;^UTILITY(U,$J,358.3,8562,1,4,0)
 ;;=4^042.
 ;;^UTILITY(U,$J,358.3,8562,2)
 ;;=^266500
 ;;^UTILITY(U,$J,358.3,8563,0)
 ;;=053.29^^53^575^43
 ;;^UTILITY(U,$J,358.3,8563,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8563,1,3,0)
 ;;=3^Herpes Zoster,Oth
 ;;^UTILITY(U,$J,358.3,8563,1,4,0)
 ;;=4^053.29
 ;;^UTILITY(U,$J,358.3,8563,2)
 ;;=^266555
 ;;^UTILITY(U,$J,358.3,8564,0)
 ;;=054.40^^53^575^42
 ;;^UTILITY(U,$J,358.3,8564,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8564,1,3,0)
 ;;=3^Herpes Simplex
 ;;^UTILITY(U,$J,358.3,8564,1,4,0)
 ;;=4^054.40
 ;;^UTILITY(U,$J,358.3,8564,2)
 ;;=^266562
 ;;^UTILITY(U,$J,358.3,8565,0)
 ;;=190.1^^53^575^83
 ;;^UTILITY(U,$J,358.3,8565,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8565,1,3,0)
 ;;=3^Orbit Malig Neoplasm
 ;;^UTILITY(U,$J,358.3,8565,1,4,0)
 ;;=4^190.1
 ;;^UTILITY(U,$J,358.3,8565,2)
 ;;=^267272
 ;;^UTILITY(U,$J,358.3,8566,0)
 ;;=190.2^^53^575^50
 ;;^UTILITY(U,$J,358.3,8566,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8566,1,3,0)
 ;;=3^Lac Gland Malig Neoplasm
 ;;^UTILITY(U,$J,358.3,8566,1,4,0)
 ;;=4^190.2
 ;;^UTILITY(U,$J,358.3,8566,2)
 ;;=^267273
 ;;^UTILITY(U,$J,358.3,8567,0)
 ;;=190.7^^53^575^52
 ;;^UTILITY(U,$J,358.3,8567,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8567,1,3,0)
 ;;=3^Lac Sac Nasolac Malig Neoplasm
 ;;^UTILITY(U,$J,358.3,8567,1,4,0)
 ;;=4^190.7
 ;;^UTILITY(U,$J,358.3,8567,2)
 ;;=^267277
 ;;^UTILITY(U,$J,358.3,8568,0)
 ;;=202.81^^53^575^61
 ;;^UTILITY(U,$J,358.3,8568,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8568,1,3,0)
 ;;=3^Lymphoma,Oth Head,Face,Neck Lymphs
 ;;^UTILITY(U,$J,358.3,8568,1,4,0)
 ;;=4^202.81
 ;;^UTILITY(U,$J,358.3,8568,2)
 ;;=^267496
 ;;^UTILITY(U,$J,358.3,8569,0)
 ;;=215.9^^53^575^85
 ;;^UTILITY(U,$J,358.3,8569,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8569,1,3,0)
 ;;=3^Oth Benign Neoplasm Connect Tissue
 ;;^UTILITY(U,$J,358.3,8569,1,4,0)
 ;;=4^215.9
 ;;^UTILITY(U,$J,358.3,8569,2)
 ;;=^267620
 ;;^UTILITY(U,$J,358.3,8570,0)
 ;;=224.2^^53^575^51
 ;;^UTILITY(U,$J,358.3,8570,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8570,1,3,0)
 ;;=3^Lac Gland,Benign Neoplasm
 ;;^UTILITY(U,$J,358.3,8570,1,4,0)
 ;;=4^224.2
 ;;^UTILITY(U,$J,358.3,8570,2)
 ;;=^267672
 ;;^UTILITY(U,$J,358.3,8571,0)
 ;;=224.5^^53^575^96
 ;;^UTILITY(U,$J,358.3,8571,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8571,1,3,0)
 ;;=3^Retina,Benign Neoplasm
 ;;^UTILITY(U,$J,358.3,8571,1,4,0)
 ;;=4^224.5
 ;;^UTILITY(U,$J,358.3,8571,2)
 ;;=^267675
 ;;^UTILITY(U,$J,358.3,8572,0)
 ;;=224.7^^53^575^28
 ;;^UTILITY(U,$J,358.3,8572,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8572,1,3,0)
 ;;=3^Duct,Sac,Nasolac Benign Neoplasm
 ;;^UTILITY(U,$J,358.3,8572,1,4,0)
 ;;=4^224.7
 ;;^UTILITY(U,$J,358.3,8572,2)
 ;;=^267677
 ;;^UTILITY(U,$J,358.3,8573,0)
 ;;=237.70^^53^575^66
 ;;^UTILITY(U,$J,358.3,8573,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8573,1,3,0)
 ;;=3^Neurofibromatosis
 ;;^UTILITY(U,$J,358.3,8573,1,4,0)
 ;;=4^237.70
 ;;^UTILITY(U,$J,358.3,8573,2)
 ;;=^278264
 ;;^UTILITY(U,$J,358.3,8574,0)
 ;;=239.6^^53^575^65
 ;;^UTILITY(U,$J,358.3,8574,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8574,1,3,0)
 ;;=3^Neoplasm,Brain,Unspec Nature
 ;;^UTILITY(U,$J,358.3,8574,1,4,0)
 ;;=4^239.6
 ;;^UTILITY(U,$J,358.3,8574,2)
 ;;=^16739
 ;;^UTILITY(U,$J,358.3,8575,0)
 ;;=239.81^^53^575^97
 ;;^UTILITY(U,$J,358.3,8575,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8575,1,3,0)
 ;;=3^Retina/Choroid Neoplasm,Unspec Nature
 ;;^UTILITY(U,$J,358.3,8575,1,4,0)
 ;;=4^239.81
 ;;^UTILITY(U,$J,358.3,8575,2)
 ;;=^338224
 ;;^UTILITY(U,$J,358.3,8576,0)
 ;;=272.0^^53^575^48
 ;;^UTILITY(U,$J,358.3,8576,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8576,1,3,0)
 ;;=3^Hypercholesterolemia
 ;;^UTILITY(U,$J,358.3,8576,1,4,0)
 ;;=4^272.0
 ;;^UTILITY(U,$J,358.3,8576,2)
 ;;=^59973
 ;;^UTILITY(U,$J,358.3,8577,0)
 ;;=340.^^53^575^63
 ;;^UTILITY(U,$J,358.3,8577,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8577,1,3,0)
 ;;=3^Multiple Sclerosis
 ;;^UTILITY(U,$J,358.3,8577,1,4,0)
 ;;=4^340.
 ;;^UTILITY(U,$J,358.3,8577,2)
 ;;=^79761
 ;;^UTILITY(U,$J,358.3,8578,0)
 ;;=345.90^^53^575^29
 ;;^UTILITY(U,$J,358.3,8578,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8578,1,3,0)
 ;;=3^Epliepsy,Unspec
 ;;^UTILITY(U,$J,358.3,8578,1,4,0)
 ;;=4^345.90
 ;;^UTILITY(U,$J,358.3,8578,2)
 ;;=^268477
 ;;^UTILITY(U,$J,358.3,8579,0)
 ;;=368.02^^53^575^23
 ;;^UTILITY(U,$J,358.3,8579,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8579,1,3,0)
 ;;=3^Deprivation Amblyopia
 ;;^UTILITY(U,$J,358.3,8579,1,4,0)
 ;;=4^368.02
 ;;^UTILITY(U,$J,358.3,8579,2)
 ;;=^265361
 ;;^UTILITY(U,$J,358.3,8580,0)
 ;;=368.11^^53^575^103
 ;;^UTILITY(U,$J,358.3,8580,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8580,1,3,0)
 ;;=3^Sudden Visual Loss
 ;;^UTILITY(U,$J,358.3,8580,1,4,0)
 ;;=4^368.11
 ;;^UTILITY(U,$J,358.3,8580,2)
 ;;=^268831
 ;;^UTILITY(U,$J,358.3,8581,0)
 ;;=368.59^^53^575^11
 ;;^UTILITY(U,$J,358.3,8581,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8581,1,3,0)
 ;;=3^Color Blindness
 ;;^UTILITY(U,$J,358.3,8581,1,4,0)
 ;;=4^368.59
 ;;^UTILITY(U,$J,358.3,8581,2)
 ;;=^87408
 ;;^UTILITY(U,$J,358.3,8582,0)
 ;;=368.60^^53^575^67
 ;;^UTILITY(U,$J,358.3,8582,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8582,1,3,0)
 ;;=3^Night Blindness
 ;;^UTILITY(U,$J,358.3,8582,1,4,0)
 ;;=4^368.60
 ;;^UTILITY(U,$J,358.3,8582,2)
 ;;=^83350
 ;;^UTILITY(U,$J,358.3,8583,0)
 ;;=368.9^^53^575^114
 ;;^UTILITY(U,$J,358.3,8583,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8583,1,3,0)
 ;;=3^Visual Disturbance,Unspec
 ;;^UTILITY(U,$J,358.3,8583,1,4,0)
 ;;=4^368.9
 ;;^UTILITY(U,$J,358.3,8583,2)
 ;;=^124001
 ;;^UTILITY(U,$J,358.3,8584,0)
 ;;=369.00^^53^575^109
 ;;^UTILITY(U,$J,358.3,8584,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8584,1,3,0)
 ;;=3^Total Blindness,Both Eyes
 ;;^UTILITY(U,$J,358.3,8584,1,4,0)
 ;;=4^369.00
 ;;^UTILITY(U,$J,358.3,8584,2)
 ;;=^15310
